Douglas Evan Godshall net worth and biography

Douglas Godshall Biography and Net Worth

Doug joined Shockwave as Chief Executive Officer in May 2017 to lead the company into US commercialization and international expansion.   This followed his most recent tenure as the CEO and a Director of HeartWare, a leader in the LVAD market. He managed the organization from a pre-commercial phase to over $250M in sales until it was acquired by Medtronic in August of 2016 for $1.1B.

Prior to HeartWare, Doug held other executive and leadership positions at Boston Scientific, including President of the Vascular Surgery Division, member of Boston Sci’s Operating Committee and Vice President of Business Development where he was responsible for more than 70 transactions, many in the arena of coronary and peripheral interventions.

Doug earned an MBA from Northeastern University and a BA in Economics from Lafayette College.

What is Douglas Evan Godshall's net worth?

The estimated net worth of Douglas Evan Godshall is at least $15.30 million as of November 14th, 2022. Mr. Godshall owns 82,926 shares of ShockWave Medical stock worth more than $15,303,993 as of February 7th. This net worth estimate does not reflect any other assets that Mr. Godshall may own. Learn More about Douglas Evan Godshall's net worth.

How do I contact Douglas Evan Godshall?

The corporate mailing address for Mr. Godshall and other ShockWave Medical executives is 5403 Betsy Ross Drive, Santa Clara CA, 95054. ShockWave Medical can also be reached via phone at (877) 775-4846 and via email at [email protected] Learn More on Douglas Evan Godshall's contact information.

Has Douglas Evan Godshall been buying or selling shares of ShockWave Medical?

Douglas Evan Godshall has not been actively trading shares of ShockWave Medical during the past quarter. Most recently, Douglas Evan Godshall sold 30,000 shares of the business's stock in a transaction on Monday, November 14th. The shares were sold at an average price of $240.81, for a transaction totalling $7,224,300.00. Following the completion of the sale, the chief executive officer now directly owns 82,926 shares of the company's stock, valued at $19,969,410.06. Learn More on Douglas Evan Godshall's trading history.

Who are ShockWave Medical's active insiders?

ShockWave Medical's insider roster includes Colin Cahill (Director), Laura Francis (Director), Douglas Godshall (CEO), Antoine Papiernik (Director), Trinh Phung (VP), Dan Puckett (CFO), Maria Sainz (Director), Frank Watkins (Director), and Isaac Zacharias (Insider). Learn More on ShockWave Medical's active insiders.

Are insiders buying or selling shares of ShockWave Medical?

In the last year, insiders at the sold shares 51 times. They sold a total of 321,045 shares worth more than $70,422,169.13. The most recent insider tranaction occured on February, 3rd when VP Trinh Phung sold 941 shares worth more than $176,183.43. Insiders at ShockWave Medical own 3.9% of the company. Learn More about insider trades at ShockWave Medical.

Information on this page was last updated on 2/3/2023.

Douglas Evan Godshall Insider Trading History at ShockWave Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/14/2022Sell30,000$240.81$7,224,300.0082,926View SEC Filing Icon  
8/11/2022Sell30,000$280.60$8,418,000.00112,926View SEC Filing Icon  
6/6/2022Sell7,400$177.32$1,312,168.00142,926View SEC Filing Icon  
5/27/2022Sell2,600$175.06$455,156.00142,926View SEC Filing Icon  
5/13/2022Sell5,000$150.00$750,000.00142,926View SEC Filing Icon  
5/11/2022Sell15,000$140.87$2,113,050.00142,926View SEC Filing Icon  
11/18/2021Sell45,000$207.28$9,327,600.00View SEC Filing Icon  
8/18/2021Sell45,000$188.08$8,463,600.00181,856View SEC Filing Icon  
5/18/2021Sell45,000$159.36$7,171,200.00181,856View SEC Filing Icon  
2/18/2021Sell45,000$121.96$5,488,200.00193,359View SEC Filing Icon  
11/17/2020Sell132,145$94.98$12,551,132.10230,083View SEC Filing Icon  
8/27/2020Sell849$60.00$50,940.0099,208View SEC Filing Icon  
8/24/2020Sell9,359$60.00$561,540.00107,718View SEC Filing Icon  
8/21/2020Sell16,750$60.02$1,005,335.00125,635View SEC Filing Icon  
8/4/2020Sell19,357$50.01$968,043.57109,002View SEC Filing Icon  
2/18/2020Sell30,000$43.23$1,296,900.0046,000View SEC Filing Icon  
11/21/2019Sell30,000$37.42$1,122,600.0046,000View SEC Filing Icon  
See Full Table

Douglas Evan Godshall Buying and Selling Activity at ShockWave Medical

This chart shows Douglas Evan Godshall's buying and selling at ShockWave Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ShockWave Medical Company Overview

ShockWave Medical logo
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
Read More

Today's Range

Now: $188.99
Low: $179.48
High: $189.25

50 Day Range

MA: $207.46
Low: $175.41
High: $253.60

2 Week Range

Now: $188.99
Low: $113.36
High: $320.54

Volume

387,694 shs

Average Volume

467,192 shs

Market Capitalization

$6.83 billion

P/E Ratio

81.11

Dividend Yield

N/A

Beta

0.97